Replies to post #60319 on Ayala Pharmaceuticals Inc (ADXS)

[DewDiligence]

I'm curious if you support the theory that the 2$ raise was related to potential "going concern" issues?

I think the 10M-share offering was triggered, at least in part, by the “going concern” issue.

(The $2.00 price of the offering wasn’t specified in advance, but rather was what the buyers were willing to pay. And was probably less than ADXS expected to get.)

When that raise was executed, we also didn't need capital right away. Why would they wait 6-9 months for a follow-up raise?

The approximately $19M proceeds from the offering solidifies ADXS’ balance sheet and dispenses with the liquidity issue for now, so there would be no point is doing another raise in the near future. In the next 6-9 months, various positive things may happen that will enable ADXS to raise capital on more favorable terms.